Ye Li
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Oncology top 10%
Papers in
- Oncology 18
- Inflammatory Biomarkers in Disease Prognosis 4
- Pancreatic and Hepatic Oncology Research 4
-
- Wnt/β-catenin signaling in development and cancer 5
- Co-authors
- Dean W. Felsher (1 shared paper)M. Gabay (1 shared paper)Rui Zhang (1 shared paper)Jun Xi (1 shared paper)Jian Zhou (5 shared papers)Jian Yang (3 shared papers)Yi Zhang (3 shared papers)Yanbo Zhu (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Frontiers in Oncology (3 papers)Frontiers in Pharmacology (3 papers)BMC Genomics (2 papers)Biomedicine & Pharmacotherapy (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ye Li
61 papers receiving 1.5k citations
Ye Li's Hit Papers
Peers
Comparison fields: 5 of 127
- Cancer Research 261
- Oncology 323
- Molecular Biology 797
- Immunology 110
- Biochemistry 30
Countries citing papers authored by Ye Li
This map shows the geographic impact of Ye Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Li more than expected).
Fields of papers citing papers by Ye Li
This network shows the impact of papers produced by Ye Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Li. The network helps show where Ye Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MYC Activation Is a Hallmark of Cancer Initiation and Maintenance Hit paper breakdown → | 2014 | 633 |
| 2 | 1999 | 95 | |
| 3 | 2016 | 67 | |
| 4 | 2011 | 54 | |
| 5 | 2018 | 53 | |
| 6 | 2018 | 53 | |
| 7 | 2021 | 42 | |
| 8 | 2017 | 40 | |
| 9 | 2024 | 30 | |
| 10 | 2020 | 29 | |
| 11 | 2021 | 28 | |
| 12 | 2014 | 26 | |
| 13 | 2019 | 25 | |
| 14 | 2020 | 24 | |
| 15 | 2020 | 24 | |
| 16 | Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China. | 2009 | 24 |
| 17 | 2017 | 23 | |
| 18 | 2019 | 21 | |
| 19 | 2020 | 21 | |
| 20 | 2024 | 16 |
About Ye Li
Ye Li is a scholar working on Oncology, Molecular Biology, Cancer Research, Pharmacology and Pathology and Forensic Medicine, having authored 67 papers that have together received 1.5k indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (5 papers), Fungal Biology and Applications (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer Mechanisms and Therapy (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Natural Compounds in Disease Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Cancer Research (261 citations), Oncology (323 citations), Molecular Biology (797 citations), Immunology (110 citations) and Biochemistry (30 citations). Ye Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dean W. Felsher, M. Gabay, Rui Zhang, Jun Xi, Jian Zhou, Jian Yang, Yi Zhang, Yanbo Zhu, Guiyuan Zou and Dechun Li. Their work appears in journals such as Annals of Oncology, Frontiers in Oncology, Frontiers in Pharmacology, BMC Genomics and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.